Ythdf1 deficiency exacerbates colitis but prevents colitis-associated cancer in mice
Ageing and Cancer Research & Treatment · 2024
DOI: 10.70401/acrt.2026.0009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ageing and Cancer Research & Treatment, 2024. Verfasst von Zhen Zhang und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Recurrent and uncontrolled inflammation of the colon may cause inflammatory bowel diseases (IBD), which are strongly associated with the onset of colitis-associated cancer (CAC). However, the molecular mechanisms linking inflammation, dysregulated growth, and tumorigenesis remain unclear. This study aims to determine the role of the N6-methyladenosine (m6A) reader YTH m6A RNA binding protein 1 (Ythdf1) in regulating colitis severity and CAC development.
Methods
Ythdf1-deficient and wild-type mice were subjected to dextran sodium sulfate (DSS)-induced colitis to evaluate disease severity, epithelial survival, goblet cell and mucus preservation, and inflammatory signaling. m6A-dependent regulation of Jak1 mRNA and the Il6-Jak1-Stat3 pathway activation was assessed through molecular analyses. Additionally, an azoxymethane (AOM)/DSS model was used to determine the impact of Ythdf1 loss on CAC development.
Results
Ythdf1 deficiency significantly worsened DSS-induced colitis, with increased epithelial damage, loss of goblet cells and mucus, impaired epithelial survival, and reduced Stat3 activation. Mechanistically, Ythdf1 recognized m6A-modified Jak1 mRNA and enhanced Jak1 protein expression, thereby maintaining the Il6-Jak1-Stat3 signaling during inflammatory stress. Despite aggravating colitis, Ythdf1 loss markedly suppressed CAC progression and reduced tumor burden.
Conclusion
Ythdf1 is a key regulator of intestinal homeostasis, maintaining the Il6-Jak1-Stat3 signaling to protect against colitis while paradoxically promoting CAC progression. These findings identify Ythdf1 as a context-dependent modulator of intestinal inflammation and tumorigenesis, highlighting its therapeutic potential in IBD and CAC.
Zitieren
APA
Zhang, Z., Zhang, J., Xu, C., Ning, Y., & Liu, B. (2024). Ythdf1 deficiency exacerbates colitis but prevents colitis-associated cancer in mice. Ageing and Cancer Research & Treatment. https://doi.org/10.70401/acrt.2026.0009
Vancouver
Zhang Z, Zhang J, Xu C, Ning Y, Liu B. Ythdf1 deficiency exacerbates colitis but prevents colitis-associated cancer in mice. Ageing and Cancer Research & Treatment. 2024. doi:10.70401/acrt.2026.0009
BibTeX
@article{Zhang2024,
author = {Zhang, Zhen and Zhang, Jie and Xu, Chenzhong and Ning, Yuping and Liu, Baohua},
title = {Ythdf1 deficiency exacerbates colitis but prevents colitis-associated cancer in mice},
journal = {Ageing and Cancer Research & Treatment},
year = {2024},
doi = {10.70401/acrt.2026.0009}
}
EUVIMED